Cabaletta Bio, Inc.
CABA
$2.54
$0.041.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -18.19% | 1.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.49% | 23.62% | |||
| Operating Income | -1.49% | -23.62% | |||
| Income Before Tax | 0.58% | -25.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.58% | -25.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.58% | -25.55% | |||
| EBIT | -1.49% | -23.62% | |||
| EBITDA | -1.77% | -23.97% | |||
| EPS Basic | 39.85% | -2.96% | |||
| Normalized Basic EPS | 39.84% | -2.96% | |||
| EPS Diluted | 39.85% | -2.96% | |||
| Normalized Diluted EPS | 39.84% | -2.96% | |||
| Average Basic Shares Outstanding | 65.27% | 21.94% | |||
| Average Diluted Shares Outstanding | 65.27% | 21.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||